For: |
Lei T, Ling X. IGF-1 promotes the growth and metastasis of hepatocellular carcinoma |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i35/10137.htm |
Number | Citing Articles |
1 |
Guanjun Xu, Jiesheng Chu, Yu Shi, Longzhang Huang, Jingzhong Fu. The regulation of proliferation and apoptosis in hepatocellular carcinoma via insulin-like growth factor 1 receptor. Growth Hormone & IGF Research 2022; 66: 101499 doi: 10.1016/j.ghir.2022.101499
|
2 |
Qihong Zhao, Yue He, Kexin Wang, Chen Wang, Hanhan Wu, Lei Gao, Anla Hu, Wanshui Yang, Sufang Wang. Dairy Consumption and Liver Cancer Risk: A Systematic Review and Dose–Response Meta-Analysis of Observational Studies. Nutrition and Cancer 2021; 73(11-12): 2821 doi: 10.1080/01635581.2020.1862255
|
3 |
Yuying Shan, Caide Lu, Jiacheng Wang, Mingyao Li, Shazhou Ye, Shengdong Wu, Jing Huang, Shizhong Bu, Fuyan Wang. IGF-1 contributes to liver cancer development in diabetes patients by promoting autophagy. Annals of Hepatology 2022; 27(4): 100697 doi: 10.1016/j.aohep.2022.100697
|
4 |
Rana Ahmed Youness, Mai Atef Rahmoon, Reem Amr Assal, Asmaa Ibrahim Gomaa, Mohamed Tarif Hamza, Imam Waked, Hend Mohamed El Tayebi, Ahmed Ihab Abdelaziz. Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression. Growth Factors 2016; 34(3-4): 128 doi: 10.1080/08977194.2016.1200571
|
5 |
Shaoyue Jin, Youjin Je. Dairy Consumption and Total Cancer and Cancer-Specific Mortality: A Meta-Analysis of Prospective Cohort Studies. Advances in Nutrition 2022; 13(4): 1063 doi: 10.1093/advances/nmab135
|
6 |
|
7 |
Nadire Özenver, Thomas Efferth. Prognostic and Therapeutic Applications of RKIP in Cancer. 2020; : 357 doi: 10.1016/B978-0-12-819612-0.00019-5
|
8 |
Surinder M. Soond, Maria V. Kozhevnikova, Anastasia S. Frolova, Lyudmila V. Savvateeva, Egor Y. Plotnikov, Paul A. Townsend, Yuan-Ping Han, Andrey A. Zamyatnin. Lost or Forgotten: The nuclear cathepsin protein isoforms in cancer. Cancer Letters 2019; 462: 43 doi: 10.1016/j.canlet.2019.07.020
|
9 |
Abeer Mostafa, Noha El-Sayed Ibrahim, Dina Sabry, Wael Fathy, Amany Y. Elkazaz. Insulin-like Growth Factor Initiates Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients through Induction of Long Non-coding Ribonucleic Acids AF085935. Open Access Macedonian Journal of Medical Sciences 2021; 9(A): 222 doi: 10.3889/oamjms.2021.5909
|
10 |
Chun-Chieh Yeh, Pei-Ying Liao, Sudhir Pandey, Su-Yung Yung, Hsueh-Chou Lai, Long-Bin Jeng, Wei-Chun Chang, Wen-Lung Ma. Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.572861
|
11 |
Li shan, Duan xiaotong, Wang Qiyi, Liu Jingxian, He Tianmu, Zhang Jianyong, Li Xiaofei. Mechanisms underlying the activity of paederus in hepatocellular carcinoma: A network pharmacology and in vitro validation approach. Pharmacological Research - Modern Chinese Medicine 2022; 3: 100089 doi: 10.1016/j.prmcm.2022.100089
|
12 |
Jiaying Dai, Tong Yin, Liying Cao. Dairy consumption and liver cancer risk: A meta‑analysis of observational studies. Oncology Letters 2024; 27(3) doi: 10.3892/ol.2024.14240
|
13 |
Kangwei Wang, Xin Nie, Zhuona Rong, Tingting Fan, Juan Li, Xinxin Wang, Huiling Li, Jianyi Dong, Jun Chen, Fujin Wang, Jingyu Wang, Aiguo Wang. B lymphocytes repress hepatic tumorigenesis but not development in Hras12V transgenic mice. International Journal of Cancer 2017; 141(6): 1201 doi: 10.1002/ijc.30823
|
14 |
Hyuk Moon, Kyungjoo Cho, Sunyeong Shin, Do Young Kim, Kwang-Hyub Han, Simon Weonsang Ro. High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway. International Journal of Molecular Sciences 2019; 20(3): 581 doi: 10.3390/ijms20030581
|
15 |
Maolei Shen, Qinzhang Wang, Shuaijun Xu, Guang Chen, Hao Xu, Xin Li, Shankun Zhao. Role of oncogenic REGγ in cancer. Biomedicine & Pharmacotherapy 2020; 130: 110614 doi: 10.1016/j.biopha.2020.110614
|
16 |
Wanshui Yang, Jing Sui, Yanan Ma, Tracey G. Simon, Dawn Chong, Jeffrey A. Meyerhardt, Walter C. Willett, Edward L. Giovannucci, Andrew T. Chan, Xuehong Zhang. A prospective study of dairy product intake and the risk of hepatocellular carcinoma in U.S. men and women. International Journal of Cancer 2020; 146(5): 1241 doi: 10.1002/ijc.32423
|
17 |
Anuradha A. Shastri, Anthony Saleh, Jason E. Savage, Tiziana DeAngelis, Kevin Camphausen, Nicole L. Simone. Dietary alterations modulate the microRNA 29/30 and IGF-1/AKT signaling axis in breast Cancer liver metastasis. Nutrition & Metabolism 2020; 17(1) doi: 10.1186/s12986-020-00437-z
|
18 |
Dan-dan Xiong, Yi-wu Dang, Peng Lin, Dong-yue Wen, Rong-quan He, Dian-zhong Luo, Zhen-bo Feng, Gang Chen. A circRNA–miRNA–mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1593-5
|
19 |
Hari Prasad, Idrees A Shah, Reuben Thomas Kurien, Sudipta Dhar Chowdhury, Sandhya S Visweswariah. An integrated picture of chronic pancreatitis derived by mapping variants in multiple disease genes onto pathogenic pathways. Human Molecular Genetics 2024; 33(21): 1887 doi: 10.1093/hmg/ddae127
|
20 |
Agnieszka Adamek, Aldona Kasprzak. Insulin-Like Growth Factor (IGF) System in Liver Diseases. International Journal of Molecular Sciences 2018; 19(5): 1308 doi: 10.3390/ijms19051308
|
21 |
Yinqi Zhang, Chengqi Gao, Fei Cao, Ying Wu, Shuanggang Chen, Xue Han, Jingqin Mo, Zhiyu Qiu, Weijun Fan, Penghui Zhou, Lujun Shen. Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.755341
|
22 |
Song Qi, Li Xu, Yongyuan Han, Hongkun Chen, Anyuan Cheng. miR-29a-3p mitigates the development of osteosarcoma through modulating IGF1 mediated PI3k/Akt/FOXO3 pathway by activating autophagy. Cell Cycle 2022; 21(18): 1980 doi: 10.1080/15384101.2022.2078614
|
23 |
Shaimaa Almohaid, Saeed Akhtar. Diet, lifestyle factors, comorbidities, and hepatocellular carcinoma risk in a middle eastern country: a case-control study. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12409-0
|
24 |
Yaroslav R. Efremov, Anastasia S. Proskurina, Ekaterina A. Potter, Evgenia V. Dolgova, Oksana V. Efremova, Oleg S. Taranov, Aleksandr A. Ostanin, Elena R. Chernykh, Nikolay A. Kolchanov, Sergey S. Bogachev. Cancer Stem Cells: Emergent Nature of Tumor Emergency. Frontiers in Genetics 2018; 9 doi: 10.3389/fgene.2018.00544
|
25 |
Hester van Mourik, Mengying Li, Sabine Baumgartner, Jan Theys, Ronit Shiri-Sverdlov. All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma. Biomedicines 2022; 10(10): 2351 doi: 10.3390/biomedicines10102351
|
26 |
Mohammed M.H. Al-Gayyar, Alaa Bagalagel, Ahmad O. Noor, Diena M. Almasri, Reem Diri. The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB. Biomedicine & Pharmacotherapy 2019; 112: 108653 doi: 10.1016/j.biopha.2019.108653
|
27 |
Yangtao Xue, Yeling Ruan, Yali Wang, Peng Xiao, Junjie Xu. Signaling pathways in liver cancer: pathogenesis and targeted therapy. Molecular Biomedicine 2024; 5(1) doi: 10.1186/s43556-024-00184-0
|
28 |
Alejandro del Castillo-Cruz, Maria Fernández-Fernández, Anna Moles. Searching for novel cellular targets for MASLD and HCC within the humble lysosomal cathepsins. Exploration of Digestive Diseases 2024; 3(6): 428 doi: 10.37349/edd.2024.00059
|
29 |
Sophie van Doorslaer de ten Ryen, Louise Deldicque. The Regulation of the Metastatic Cascade by Physical Activity: A Narrative Review. Cancers 2020; 12(1): 153 doi: 10.3390/cancers12010153
|
30 |
Baha Aldeen Bani Fawwaz, Aimen Farooq, Mengni Guo, Gurdeep Singh, Sarfraz Ahmad. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 341 doi: 10.1016/B978-0-323-99283-1.00014-8
|
31 |
Yong-Shiou Lin, Wen-Ling Cheng, Jui-Chih Chang, Ta-Tsung Lin, Yi-Chun Chao, Chin-San Liu. IGF-1 as a Potential Therapy for Spinocerebellar Ataxia Type 3. Biomedicines 2022; 10(2): 505 doi: 10.3390/biomedicines10020505
|
32 |
Shingo Ito, Gentaro Honda, Yu Fujino, Seiryo Ogata, Mio Hirayama-Kurogi, Sumio Ohtsuki. Knockdown of Orphan Transporter SLC22A18 Impairs Lipid Metabolism and Increases Invasiveness of HepG2 Cells. Pharmaceutical Research 2019; 36(3) doi: 10.1007/s11095-018-2565-4
|